M&A Update – June 7

– PWSC to be acquired by Bain Capital for $22.80 cash per share, 37.0% premium, $5.6 billion
– VNDA received unsolicited proposal from Cycle Pharmaceuticals at $8.00 cash per share, 58.4% premium
– CORZ rejected $5.75 unsolicited proposal from CoreWeave
– HCP / IBM cleared German FCO
– HIBB HSR expiry